EquityFlow
›
Companies
› Biofidelity
Biofidelity
Biotech
· Cambridge, GB
Commercial-stage genomic-technology company.
Funding history
Date
Round
Amount
Apr 2024
Funding round
Biofidelity, a Cambridge genomic-technology biotech, raised $24M from investors including Octopus Ventures and Agilent Technologies.
$24M
Investors
Agilent Technologies
BlueYard Capital
Octopus Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →